| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 01/03/2001 | EP1064015A2 Receptor derived peptides as modulators of receptor activity |
| 01/03/2001 | EP1064013A1 $i(IN VITRO) FORMATION OF CONGOPHILIC MALTESE-CROSS AMYLOID PLAQUES TO IDENTIFY ANTI-PLAQUE THERAPEUTICS FOR THE TREATMENT OF ALZHEIMER'S AND PRION DISEASES |
| 01/03/2001 | EP1064010A1 Peptide compositions and formulations and use of same |
| 01/03/2001 | EP1064006A1 Treatment of ulcerative colitis with tropomyosin isoforms and monoclonal antibodies to tropomyosin isoforms |
| 01/03/2001 | EP1064001A2 Methods and compositions for treating and preventing mucositis |
| 01/03/2001 | EP1063999A1 Epiallopregnanolone in the treatment of cns disorders |
| 01/03/2001 | EP1063998A1 Medicament for preventing and/or treating a mammary carcinoma, containing a steroidal aromatase inhibitor |
| 01/03/2001 | EP1063997A2 Peripheral-type benzodiazepine receptor: a tool for detection, diagnosis, prognosis, and treatment of cancer |
| 01/03/2001 | EP1063996A1 Pharmaceutical compositions containing in combination two antagonists selective of arginine-vassopressin v receptors, even of v 1a? and v 2? receptors |
| 01/03/2001 | EP1063991A1 Statin-matrix metalloproteinase inhibitor combinations |
| 01/03/2001 | EP1063990A1 Therapy of estrogen-associated disorders |
| 01/03/2001 | EP1063989A1 Prevention and treatment of adhesions |
| 01/03/2001 | EP1063988A1 Hesperidin and hesperetin as inhibitor of acyl coa-cholesterol-o-acyltransferase, inhibitor ofmacrophage-lipid complex accumulation on the arterial wall and preventive or treating agent for hepatic diseases |
| 01/03/2001 | EP1063987A1 Dietary control of arachidonic acid metabolism |
| 01/03/2001 | EP1063985A1 Benzoates derivatives for inhibiting angiogenesis |
| 01/03/2001 | EP1063984A1 Inflammatory cell inhibitors |
| 01/03/2001 | EP1063982A2 Antagonists for treatment of cd11/cd18 adhesion receptor mediated disorders |
| 01/03/2001 | EP1063980A2 Methods for decreasing beta amyloid protein production |
| 01/03/2001 | EP1063887A1 P53-dependent secretion of growth inhibitory factors |
| 01/03/2001 | EP1063882A1 Skin equivalent and methods of forming and using same |
| 01/03/2001 | EP0934060A4 Dietary supplements |
| 01/03/2001 | EP0842169B1 Benzothiophene compounds |
| 01/03/2001 | EP0832057B1 Diaromatic propynyl or dienyl compounds |
| 01/03/2001 | EP0815126B1 Bicyclic tachykinins antagonists, preparation thereof and their use in pharmaceutical composition |
| 01/03/2001 | EP0787127B1 5-lipoxygenase inhibitors |
| 01/03/2001 | EP0722312B1 Pharmaceutical composition to enhance tissue healing and regeneration and application kit comprising it |
| 01/03/2001 | EP0656890B1 Novel method for preparing ergothioneine |
| 01/03/2001 | CN1278866A MPL ligand analogs |
| 01/03/2001 | CN1278825A Sarcodictyin and eleutherobin useful for stabilising microtubules |
| 01/03/2001 | CN1278822A 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors |
| 01/03/2001 | CN1278821A Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase |
| 01/03/2001 | CN1278820A Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase |
| 01/03/2001 | CN1278815A 3-oxo-2(H)-1,2,4-triazine derivativs as ligands of 5HT1A receptors |
| 01/03/2001 | CN1278806A Aminothiazole inhibitors of cyclin dependent protein kinasses of cells |
| 01/03/2001 | CN1278805A Novel heterocyclioally substituted and a-hydroxycarboxlic acid derivatives, method for producing the same and their use as endothelin receptor antagonists |
| 01/03/2001 | CN1278800A Cyclohexane derivatives difunctionalised in 1.4 as ligands of 5T hia receptors |
| 01/03/2001 | CN1278797A Oxo-substituted compouns, process of making, and compositions and methods for inhibiting parp activity |
| 01/03/2001 | CN1278795A Process for making diaryl pyridines useful as cox-2 inhibitors |
| 01/03/2001 | CN1278794A Substituted di-hydroxyl-indol derivatives as protein tyrosine kinase and as protein serine/threenine kinase inhibitors |
| 01/03/2001 | CN1278731A Use of mirtazapine for treating sleep apneas |
| 01/03/2001 | CN1278727A A combination of a monomine oxidase inhibitor and a hs-ht antagonist or partial agonist |
| 01/03/2001 | CN1278726A IL-8 receptor antagonists |
| 01/03/2001 | CN1278725A Indeno [1,2-c]-naphtho [1,2-C]- and benzo [6,7] cyclohepta [1,2-C] pyrazole derivatives |
| 01/03/2001 | CN1278724A Indeno [1,2-c] pyrazole derivatives for inhibiting tyrosine kinase activty |
| 01/03/2001 | CN1278721A IL-8 receptor antagonists |
| 01/03/2001 | CN1278530A Novel peptide derivative |
| 01/03/2001 | CN1278428A Dongxing foot lotion |
| 01/03/2001 | CN1060171C Substituted biphenyl isoxazole sulfonamides |
| 01/03/2001 | CN1060164C SIN-IA cyclodextriun inclusion complexes |
| 01/03/2001 | CN1060163C Acylated aminoalknimidazoles and aminoalkyl triazoles |
| 01/03/2001 | CN1060085C Chinese patent medicine mixture for treating hyperplasia of mamary glands |
| 01/03/2001 | CN1060069C Body-bilding liquor |
| 01/03/2001 | CN1060054C 'Funaowan'-medicinal pill for recovering brains and production technology thereof |
| 01/03/2001 | CN1060053C Proprietary traditional Chinese medicine for anti-senility and the prepn. method |
| 01/03/2001 | CN1060039C Inhibition of smooth muscle cell migration by (R)-amlodipine |
| 01/02/2001 | US6169167 Antibodies to ligands for HEK4 receptors |
| 01/02/2001 | US6169117 Increasing the oxygen concentration of the blood while avoiding the formation of bubbles which tend to occlude capillaries |
| 01/02/2001 | US6169105 Potentiating the action of paroxetine in increasing the availability of serotonin, norepinephrine and dopamine in the brain by administering paroxetine to a patient in need thereof in combination with way 100635 |
| 01/02/2001 | US6169104 Compounds bind tubulin and exhibit anti-mitotic properties; using such compounds to inhibit abnormal cell mitosis and, in particular, to inhibit tumor cell growth |
| 01/02/2001 | US6169100 Pharmaceutical composition |
| 01/02/2001 | US6169099 Pharmaceutical composition |
| 01/02/2001 | US6169097 1-(1,2-Disubstituted piperidinyl)-4-substituted piperidine derivatives |
| 01/02/2001 | US6169096 For inhibiting tumor growth in a mammal |
| 01/02/2001 | US6169095 For prevention and/or treatment of bradykinin or its analogues mediated diseases in the eye, such as allergy, inflammation and pain of the eye |
| 01/02/2001 | US6169092 3-Ureido-pyridofurans and -pyridothiophenes for the treatment of inflammatory processes |
| 01/02/2001 | US6169091 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 01/02/2001 | US6169090 Heterocyclic compounds and their therapeutic use |
| 01/02/2001 | US6169089 Nitric oxide synthase inhibitors; treatment of arthritis |
| 01/02/2001 | US6169087 An enzyme inhibitor for treating type i diabetes, type ii diabetes, impaired glucose tolerance, insulin resistance, obesity, autoimmune diseases, diseases with dysfunctions of the coagulation system, allergic diseases, cancer, psoriasis |
| 01/02/2001 | US6169073 An oligopeptide or polypeptide for activating dna binding of wild-type p53 and select tumor-derived p53 mutants; use in therapy of cancer and other disorders characterized by excessive proliferation of certain cells and tissues |
| 01/02/2001 | US6169069 Therapeutic/cosmetic compositions comprising CGRP antagonists for treating the eyes or eyelids |
| 01/02/2001 | US6169060 Body and hair cleanser composition that contains a sulfosuccinate anionic surfactant, polyoxyethylene-alkylsulfate anionic surfactant, at least one amphoteric surfactant, and polyoxyethylene-sorbitan nonionic |
| 01/02/2001 | US6168920 Extracellular adhesive proteins |
| 01/02/2001 | US6168807 Low molecular weight components of shark cartilage, processes for their preparation and therapeutic uses thereof |
| 01/02/2001 | US6168791 Antibodies that bind immunomodulators |
| 01/02/2001 | US6167887 Selected C-10 perfluorinated hydrocarbons for liquid ventilation and artificial blood |
| 01/02/2001 | CA2228932C Use of plasminogen activators to stimulate local bone growth |
| 01/02/2001 | CA2187274C Treatment of partial growth hormone insensitivity syndrome |
| 01/02/2001 | CA2183313C Novel indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase |
| 01/02/2001 | CA2154721C 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative |
| 01/02/2001 | CA2106172C Use of 2-(3,4-dimethoxycinnamoyl)aminobenzoic acid for the treatment of restenosis associated with coronary intervention |
| 01/02/2001 | CA2094424C Method of treating osteoporosis with 1.alpha.,24(r)-dihydroxy-22(e)-dehydro-vitamin d3 |
| 01/02/2001 | CA2027596C Compositions containing hyaluronic acid complexes with zinc or cobalt |
| 01/02/2001 | CA2001572C Compositions for treating tobacco withdrawal symptoms |
| 01/02/2001 | CA1341162C Sbustituted aminomethyltetralins and their heterocyclic analogues |
| 12/30/2000 | CA2313105A1 Treatment for diabetic complications |
| 12/30/2000 | CA2313063A1 Combinations of aldose reductase inhibitors and selective cyclooxygenase-2 inhibitors |
| 12/29/2000 | CA2300467A1 Cancer vaccines |
| 12/28/2000 | WO2000079003A1 Polymorphisms in the human hmg-coa reductase gene |
| 12/28/2000 | WO2000079000A1 Method for detection of early-onset alzheimer's disease |
| 12/28/2000 | WO2000078980A1 Method for producing plants with increased flavonoid and phenolic compound content |
| 12/28/2000 | WO2000078972A2 Regulation with binding cassette transporter protein abc1 |
| 12/28/2000 | WO2000078971A2 Atp binding cassette transporter protein abc1 popypeptides |
| 12/28/2000 | WO2000078954A2 Human transcriptional regulator proteins |
| 12/28/2000 | WO2000078953A2 Human transport proteins |
| 12/28/2000 | WO2000078941A2 Methods and products for manipulating uncoupling protein expression |
| 12/28/2000 | WO2000078815A1 ANTI-αvβ3? RECOMBINANT HUMAN ANTIBODIES, NUCLEIC ACIDS ENCODING SAME AND METHODS OF USE |
| 12/28/2000 | WO2000078812A1 Method and compounds for inhibiting activity of serine elastases |
| 12/28/2000 | WO2000078811A1 Human antithrombin variants |
| 12/28/2000 | WO2000078805A1 Peptide having preptin functionality |